Henry Esber

Corporate Officer/Principal chez Esber D&D Consulting

Profil

Henry Jemil Esber was the founder of Bio-Quant, Inc. founded in 2000 where he held the title of Chief Business Officer & Senior Vice President.
Dr. Esber is also the founder of Biosignature Diagnostics, Inc., Advanced Drug Delivery, Inc. Dr. Esber's current job is as Principal at Esber D&D Consulting since 2005.
Dr. Esber's former jobs include Director & Executive Vice President at Apricus Biosciences, Inc. from 2009 to 2013, Director at Galectin Therapeutics, Inc. from 2006 to 2009, Director at Innovus Pharmaceuticals, Inc. from 2011 to 2019, Director at Avanyx Therapeutics, Inc. from 2009 to 2010, Director at Primedica Corp, Director at Charles River Laboratories Edinburgh Ltd. from 2000 to 2005, Director at Mason Laboratories, Inc., Independent Director at Boston Therapeutics, Inc. from 2012 to 2016, Director at rEVO Biologics, Inc., Independent Director at BioXyTran, Inc., Director at BioXyTran, Inc., Vice President at TSI Corp, and Vice President at Primedica Cambridge, Inc. Dr. Esber's education includes an undergraduate degree from The College of William & Mary, a graduate degree from The University of North Carolina at Charlotte, and a doctorate degree from West Virginia University School of Medicine.

Postes actifs de Henry Esber

Sociétés	Poste	Début
Esber D&D Consulting	Corporate Officer/Principal	01/01/2005

Anciens postes connus de Henry Esber

Sociétés	Poste	Fin
INNOVUS PHARMACEUTICALS INC	Président	-
Oxygen Therapy, Inc.	Directeur/Membre du Conseil	03/08/2018
NANOMIX CORPORATION	Directeur/Membre du Conseil	11/09/2016
Apricus Biosciences, Inc.	Directeur/Membre du Conseil	04/01/2013
Avanyx Therapeutics, Inc.	Directeur/Membre du Conseil	30/11/2010